OSMOL THERAPEUTICS
Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy. The company was founded in 2016 and is headquartered in New Haven, Connecticut, United States.
OSMOL THERAPEUTICS
Social Links:
Industry:
Health Care Pharmaceutical Therapeutics
Founded:
2016-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.osmoltherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
617-719-9406
Total Funding:
5.2 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail IPv6 Microsoft Azure DNS Cloudflare Hosting Cloudflare DNS CPanel SSL Oracle Cloud
Current Employees Featured
Investors List
Koax Investment Partners
Koax Investment Partners investment in Series A - Osmol Therapeutics
Official Site Inspections
http://www.osmoltherapeutics.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Osmol Therapeutics"
About Us — OSMOL Therapeutics
Osmol Therapeutics is a clinical stage company advancing a first-in-class preventative treatment for chemotherapy-induced peripheral neuropathy (CIPN) and chemotherapy-induced cognitive impairment (CICI), debilitating conditions …See details»
OSMOL Therapeutics
Each year, hundreds of thousands of cancer patients face the debilitating side effects of their lifesaving chemotherapy. Nearly 50% of patients receiving taxane-based therapy must choose between risking sub-optimal cancer treatment …See details»
Osmol Therapeutics - Crunchbase Company Profile
Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy. The company was founded in 2016 and is headquartered in New Haven, Connecticut, United States.See details»
Osmol Therapeutics - LinkedIn
Osmol Therapeutics | 420 followers on LinkedIn. Addressing the urgent need of patients faced with the challenges of CIPN and CICI through the advancement of OSM-0205 | Osmol …See details»
Osmol Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Osmol Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Leadership - Osmol Therapeutics
Bob Linke is a biopharma entrepreneur with a proven track record building and leading emerging companies through all phases of growth – from product development and clinical studies to successful commercialization, partnership …See details»
Osmol Therapeutics, Inc. - BIO CEO & Investor Conference | BIO
Feb 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ...See details»
Osmol Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Osmol. Use the PitchBook Platform to explore the full profile.See details»
OSMOL THERAPEUTICS, INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for OSMOL THERAPEUTICS, INC. of New Haven, CT. Get the latest business insights from Dun & …See details»
Nextsource | Company Profile | Osmol Therapeutics
Explore the company profile of Osmol Therapeutics (osmoltherapeutics.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Osmol Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Explore Osmol Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 news, Disease Domain:Nervous System Diseases, Technology Platform ...See details»
Osmol Therapeutics - Overview, News & Similar companies
May 15, 2024 Osmol Therapeutics contact info: Phone number: (203) 606-5600 Website: www.osmoltherapeutics.com What does Osmol Therapeutics do? Osmol Therapeutics is a …See details»
Osmol Therapeutics Announces Closing of Series A-1 Funding to …
Apr 10, 2022 Funding will support development of OSM-0205 through IND filing. New Haven, CT. April 12, 2022 – Osmol Therapeutics, a privately held biopharmaceutical company …See details»
Osmol Therapeutics, Inc. Overview | SignalHire Company Profile
Osmol Therapeutics, Inc. is a development-stage biopharma company based in New Haven, Connecticut advancing a novel treatment to prevent chemotherapy-induced peripheral …See details»
Our Approach - OSMOL Therapeutics
Our Approach At Osmol Therapeutics, we are focused on advancing OSM-0205, a patented drug with a unique, first-in-class mechanism for modulating intracellular calcium, a known trigger for …See details»
Osmol Therapeutics - Products, Competitors, Financials, …
Osmol Therapeutics Appoints Christopher S. Eklund to its Board of Directors. May 16, 2024. May 15, 2024 Christopher S. Eklund NEW HAVEN, Conn., May 15, 2024 (GLOBE NEWSWIRE) — …See details»
Osmol Therapeutics Announces Appointment of Teresa Bitetti, …
Sep 8, 2022 About Osmol Therapeutics Osmol Therapeutics is a privately held biopharma company focused on developing a treatment to prevent chemotherapy-induced peripheral …See details»
Therapeutic Areas — OSMOL Therapeutics
Taxanes cross the blood-brain barrier causing damage to the central nervous system (CNS) leading to cognitive impairment. CICI impacts attention, concentration, and executive function …See details»
Press Releases - Osmol Therapeutics
Dec 21, 2022 Osmol Therapeutics Provides Corporate Update at BIOTECH SHOWCASE 2023 December 21, 2022 / 0 Comments / in Press Releases / by malford. Osmol Therapeutics, …See details»
News — OSMOL Therapeutics
9.29.21 - CEO of Osmol Therapeutics Leads Virtual Charge to Develop Ground-Breaking Treatment for Prevent Chemo Side-Effects Bob Linke, CEO of Osmol, was interviewed for the …See details»